Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

Rheumatoid arthritis is an autoimmune condition, causing inflammation and pain. Yet pain may persist even when inflammation has been treated. This residual pain, called nociplastic pain, has symptoms of a chronic pain condition called fibromyalgia. There are few effective therapies to address this residual pain. Published literature shows that fibromyalgia can be treated by neurofeedback, a noninvasive method that is based on the voluntary modulation of cortical activity. In this pilot study, the investigators want to test the effect of neurofeedback on the fibromyalgia component of pain in rheumatoid arthritis, and also to investigate its effects on related symptoms such as fatigue and sleep disturbance.

NCT Number	NCT06240299
Lead Sponsor	NHS Greater Glasgow and Clyde Collaborators: University of Glasgow
Conditions	Rheumatoid Arthritis, Chronic Widespread Pain
Enrollment	16 participants
Start Date	2024-06-24
Primary Completion	2027-01-29 (estimated)
Study Completion	2027-01-29 (estimated)
Updated on ClinicalTrials.gov	2025-06-15